Bill > SB941

This bill requires pharmaceutical manufacturers to provide comprehensive ingredient disclosure for all pharmaceutical products, including prescription drugs, over-the-counter medications, vaccines, and research products. Manufacturers must publish a detailed list of ingredients that includes chemical and common names, origins of biological materials, ingredient purposes, and precise quantities, with special requirements for products using gene-based technologies like mRNA. The ingredient information must be submitted to the State Board of Pharmacy, published on the manufacturer's website, and included in product labeling. The bill establishes significant penalties for non-compliance, including substantial monetary fines ranging from $50,000 to $250,000 per product violation, potential suspension of product distribution rights, and even criminal misdemeanor charges for intentional misrepresentation. Individuals who are harmed by non-compliance can pursue civil actions, including class action lawsuits, seeking economic, non-economic, and punitive damages. The bill also protects whistleblowers who report violations and gives the Legislature exclusive rule-making authority. Notably, the bill stipulates that individual rights cannot be suspended during national emergencies, and the ingredient disclosure requirements remain in effect regardless of emergency declarations. The legislation will become effective on January 1, 2026, and will be codified in the Oklahoma Statutes.

Health and Social Services

http://www.oklegislature.gov/BillInfo.aspx?Bill=sb941&Session=2600